George G Nomikos Selected Research

Injections

2/2005

Fluoxetine disrupts the integration of anxiety and aversive memories.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

George G Nomikos Research Topics

Disease

9	Major Depressive Disorder (Major Depressive Disorders) 01/2020 - 12/2005
8	Schizophrenia (Dementia Praecox) 12/2011 - 05/2002
2	Cognitive Dysfunction 04/2017 - 02/2003
2	Body Weight (Weight, Body) 01/2017 - 03/2016
2	Mania (Manias) 05/2010 - 03/2009
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 06/2007 - 03/2006
2	Substance-Related Disorders (Drug Abuse) 12/2005 - 05/2003
1	Neurobehavioral Manifestations 01/2020
1	Postpartum Depression (Post-Natal Depression) 01/2020
1	Nausea 03/2016
1	Vomiting 03/2016
1	Sleep Initiation and Maintenance Disorders (Insomnia) 03/2016
1	AIDS-Related Complex (ARC) 12/2014
1	Bipolar Disorder (Manic Depressive Psychosis) 03/2009
1	Central Nervous System Diseases (CNS Diseases) 10/2008
1	Catalepsy 03/2008
1	Mental Disorders (Mental Disorder) 06/2007
1	Hypersensitivity (Allergy) 06/2007
1	Memory Disorders (Memory Loss) 03/2006
1	Alzheimer Disease (Alzheimer's Disease) 03/2006
1	Shock 02/2006
1	Mood Disorders (Mood Disorder) 12/2005
1	Obesity 12/2005
1	Weight Gain 12/2005
1	Anxiety Disorders (Anxiety Disorder) 02/2005
1	Psychotic Disorders (Schizoaffective Disorder) 02/2003
1	Tobacco Use Disorder (Nicotine Dependence) 07/2002
1	Hypothermia 06/2002

Drug/Important Bio-Agent (IBA)

7	VortioxetineIBA 01/2020 - 03/2016
5	Antipsychotic Agents (Antipsychotics)IBA 12/2011 - 05/2002
4	Dextroamphetamine (Dexedrine)FDA LinkGeneric 12/2011 - 11/2003
2	Antidepressive Agents (Antidepressants)IBA 11/2018 - 12/2005
2	Olanzapine (Zyprexa)FDA Link 12/2011 - 05/2002
2	Cocaine (Cocaine HCl)IBA 03/2008 - 05/2003
2	Acetylcholine (Acetylcholine Chloride)FDA Link 03/2008 - 05/2002
2	Dopamine (Intropin)FDA LinkGeneric 06/2007 - 02/2003
2	Anti-Anxiety Agents (Anxiolytics)IBA 02/2006 - 02/2005
2	CannabinoidsIBA 12/2005 - 05/2003
1	Paroxetine (Paxil)FDA LinkGeneric 01/2020
1	Escitalopram FDA Link 01/2020
1	Citalopram FDA LinkGeneric 01/2020
1	Sertraline (Zoloft)FDA LinkGeneric 01/2020
1	zuranoloneIBA 01/2020
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2020
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 04/2017
1	EnzymesIBA 01/2017
1	AcidsIBA 12/2014
1	AMPA Receptors (AMPA Receptor)IBA 12/2014
1	N-Methylaspartate (NMDA)IBA 12/2014
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2014
1	Messenger RNA (mRNA)IBA 12/2014
1	Aripiprazole (Abilify)FDA Link 05/2010
1	Glycine Plasma Membrane Transport ProteinsIBA 10/2008
1	Haloperidol (Haldol)FDA LinkGeneric 03/2008
1	Nicotine FDA Link 06/2007
1	Nicotinic AgonistsIBA 06/2007
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 03/2006
1	AntibodiesIBA 03/2006
1	Cholinergic Agents (Cholinergics)IBA 03/2006
1	Muscarinic M4 ReceptorIBA 02/2006
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 12/2005
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 12/2005
1	Fluoxetine (Prozac)FDA LinkGeneric 02/2005
1	Serotonin Receptor Agonists (Serotonin Receptor Agonist)IBA 11/2003
1	Lysergic Acid Diethylamide (LSD)IBA 11/2003
1	Dopamine Agents (Dopaminergic Agents)IBA 11/2003
1	Pharmaceutical PreparationsIBA 05/2003
1	CatecholaminesIBA 02/2003
1	Serotonin (5 Hydroxytryptamine)IBA 02/2003
1	RimonabantIBA 02/2003
1	Cannabinoid Receptor AntagonistsIBA 02/2003
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 02/2003
1	anandamide (arachidonylethanolamide)IBA 06/2002
1	virodhamineIBA 06/2002
1	Clozapine (Clozaril)FDA LinkGeneric 05/2002
1	NeurotensinIBA 05/2002

Therapy/Procedure

3	Therapeutics 06/2007 - 07/2002
1	Drug Therapy (Chemotherapy) 03/2009
1	Self Medication 06/2007
1	Injections 02/2005